FibroBiologics, Inc. (FBLG) SEC Filings & Financial Intelligence
FibroBiologics, Inc. (FBLG) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FBLG
CIK: 1958777
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerAlexander Dundara
Audit LocationEast Brunswick, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| POS AM | 2026-10-13 | — | POS AM | 0001193125-26-420449 | View SEC Doc Filr Page |
| POS AM | 2026-10-13 | — | POS AM | 0001193125-26-420437 | View SEC Doc Filr Page |
| D | 2026-10-13 | — | D Filing | 0001493152-26-046663 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-07 | 8-K | 0001193125-26-418065 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | 8-K | 0001193125-26-395511 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-17 | — | SCHEDULE 13D Filing | 0001493152-26-043112 | View SEC Doc Filr Page |
| D | 2026-09-16 | — | D Filing | 0001493152-26-042792 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | 4 | 0001493152-26-042794 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391310 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-09 | — | DEFA14A | 0001193125-26-386485 | View SEC Doc Filr Page |
| 3 | 2026-09-01 | 2026-08-20 | 3 | 0001493152-26-041112 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-20 | 8-K | 0001193125-26-362027 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003577 | View SEC Doc Filr Page |
| 10-Q | 2026-07-31 | 2026-06-30 | 10-Q | 0001193125-26-328454 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-31 | 2026-09-17 | DEF 14A | 0001193125-26-326818 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-22 | 8-K | 0001193125-26-316067 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-17 | 2026-09-17 | PRE 14A | 0001193125-26-307822 | View SEC Doc Filr Page |
| EFFECT | 2026-07-16 | — | EFFECT Filing | 9999999995-26-002341 | View SEC Doc Filr Page |
| 424B3 | 2026-07-16 | — | 424B3 | 0001193125-26-306114 | View SEC Doc Filr Page |
| 3 | 2026-07-16 | 2026-07-08 | 3 | 0001493152-26-033509 | View SEC Doc Filr Page |
| S-3 | 2026-07-10 | — | S-3 | 0001193125-26-299884 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-02 | 8-K | 0001193125-26-299290 | View SEC Doc Filr Page |
| D | 2026-06-29 | — | D Filing | 0001493152-26-031095 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-25 | 8-K | 0001193125-26-288468 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-23 | 4 | 0001493152-26-029851 | View SEC Doc Filr Page |